Literature DB >> 10766820

Protein kinase C-beta and oxygen deprivation. A novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature.

S F Yan1, J Lu, Y S Zou, W Kisiel, N Mackman, M Leitges, S Steinberg, D Pinsky, D Stern.   

Abstract

Fibrin deposition is a salient feature of hypoxemic vasculature and results from induction of tissue factor. Such tissue factor expression in an oxygen deficient environment is driven by the transcription factor Early Growth Response (Egr)-1. Using homozygous null mice for the protein kinase C beta-isoform gene (PKCbeta null), PKCbeta is shown to be upstream of Egr-1 in this oxygen deprivation-mediated pathway for triggering procoagulant events. Whereas wild-type mice exposed to hypoxia (6%) displayed a robust increase in tissue factor transcripts and antigen, and vascular fibrin deposition, PKCbeta null animals showed a markedly blunted response. Consistent with a central role for Egr-1 in hypoxia-induced expression of tissue factor, PKCbeta null mice subjected to oxygen deprivation displayed at most a minor elevation in Egr-1 transcripts, antigen, and intensity of the gel shift band by electrophoretic mobility shift assay, compared with normoxic animals. These data firmly establish PKCbeta as a trigger for events leading to induction of Egr-1 and tissue factor under hypoxic conditions, and provide insight into a biologic cascade whereby oxygen deprivation recruits targets of PKCbeta and Egr-1, thereby amplifying the cellular response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766820     DOI: 10.1074/jbc.275.16.11921

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Egr-1: is it always immediate and early?

Authors:  S F Yan; D J Pinsky; N Mackman; D M Stern
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 3.  High altitude hypoxia: an intricate interplay of oxygen responsive macroevents and micromolecules.

Authors:  S Sarkar; P K Banerjee; W Selvamurthy
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 4.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury.

Authors:  Chun Huang; Jong Sun Chang; Yunlu Xu; Qing Li; Yu Shan Zou; Shi-Fang Yan
Journal:  Atherosclerosis       Date:  2010-06-04       Impact factor: 5.162

Review 6.  Hypoxia-responsive transcription factors.

Authors:  Eoin P Cummins; Cormac T Taylor
Journal:  Pflugers Arch       Date:  2005-07-09       Impact factor: 3.657

Review 7.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 8.  Atherosclerosis and restenosis: is there a role for RAGE?

Authors:  Peter Nawroth; Angelika Bierhaus; Mario Marrero; Hiroshi Yamamoto; David M Stern
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

9.  Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.

Authors:  Elizabeth L Kramer; Elizabeth M Mushaben; Patricia A Pastura; Thomas H Acciani; Gail H Deutsch; Gurjit K Khurana Hershey; Thomas R Korfhagen; William D Hardie; Jeffrey A Whitsett; Timothy D Le Cras
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

10.  PKCbeta regulates ischemia/reperfusion injury in the lung.

Authors:  Tomoyuki Fujita; Tomohiro Asai; Martin Andrassy; David M Stern; David J Pinsky; Yu Shan Zou; Morihito Okada; Yoshifumi Naka; Ann Marie Schmidt; Shi-Fang Yan
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.